What is Hemostemix Inc?
, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 10.80M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.